Our Impact

EMO Health empowers substance use treatment programs with real-time pharmacist support, targeted training, and data-driven tools that reduce medication errors and improve care quality. From frontline staff education to statewide system reform, our work ensures safer, more effective medication use for the communities that need it most.

Our Role in the
Substance Use Ecosystem

EMO serves the entire continuum of care

Every BSAS Facility,
Every Bed

EMO Health’s staff is embedded across all BSAS regions, bringing hands-on technical assistance, compliance expertise, and ongoing education directly to treatment programs.

By supporting more than 6,500 beds statewide, we help facilities maintain the highest standards of care, ensure staff are confident and prepared, and ultimately improve recovery outcomes for patients.

2025 by the Numbers

2025 was a landmark year for EMO Health. Through our partnerships with facilities across Massachusetts, we expanded our reach to every region of the state, strengthened support for more patients, and equipped thousands of staff with the tools and training they need to provide high-quality care.

By keeping our services free of charge to facilities, we ensured that resources were directed where they matter most, improving patient outcomes and advancing recovery.

Map of the United States showing different states in various shades of blue and green.

2,435 medications reviewed by a pharmacist

93% of patients showed improved adherence to medications

86% of all medications were counseled upon

185 unnecessary medication discontinued

82% of participants had medication-related problems identified and resolved by pharmacist intervention

100% of patients felt they understood their medications better

$59,023.01 total cost avoidance

Technical Assistance
Needed per Region

EMO Health provided a total of 720 discrete Technical Assistance Benefits to programs statewide. These benefits included activities such as policy implementation, workflow redesign, documentation system overhauls, and environmental or storage space optimization.

Facility program evaluations increased 166% from FY24.

Education & Trainings

  • 987 individuals reached through EMO Health-led trainings (in-person, live webinars, and self-paced modules)

  • 317 staff trained as BSAS Medication Specialists & Supervisors across 82 unique facilities

  • 592 attendees at EMO Health’s naloxone distribution webinar series, with 98% reporting increased knowledge and confidence

Medication Therapy Management (MTM)

The Medication Therapy Management (MTM) initiative was designed to strengthen medication safety, adherence, and optimization across BSAS programs by directly engaging facilities in comprehensive reviews of their prescribing and administration practices. Through targeted technical assistance, EMO Health partnered with staff to identify and resolve medication-related issues, enhance accuracy in documentation, and promote best practices for resident-centered care. The initiative not only provided real-time support to facilities but also built long-term capacity by equipping staff with practical tools to monitor outcomes, reduce risks such as diversion or duplication, and ensure consistent alignment with clinical and regulatory standards. This work directly supported improved health outcomes for residents while advancing system-wide improvements in medication management.

125 Patients Enrolled in the Pilot